Published in J Ophthalmic Inflamm Infect on November 27, 2011
Spectral-domain optical coherence tomographic features of choroidal neovascular membranes in multifocal choroiditis and punctate inner choroidopathy. Graefes Arch Clin Exp Ophthalmol (2015) 0.85
A new kind of labyrinth-like capillary is responsible for leakage from human choroidal neovascular endothelium, as investigated by high-resolution electron microscopy. Graefes Arch Clin Exp Ophthalmol (2014) 0.78
Ranibizumab for neovascular age-related macular degeneration. N Engl J Med (2006) 30.63
Pericyte production of cell-associated VEGF is differentiation-dependent and is associated with endothelial survival. Dev Biol (2003) 2.57
Intravitreal bevacizumab (avastin) for choroidal neovascularization secondary to central serous chorioretinopathy, secondary to punctate inner choroidopathy, or of idiopathic origin. Am J Ophthalmol (2007) 1.95
Subfoveal choroidal neovascularization in punctate inner choroidopathy. Surgical management and pathologic findings. Ophthalmology (1996) 1.35
Surgical removal vs observation for subfoveal choroidal neovascularization, either associated with the ocular histoplasmosis syndrome or idiopathic: II. Quality-of-life findings from a randomized clinical trial: SST Group H Trial: SST Report No. 10. Arch Ophthalmol (2004) 1.34
Impact of vessel maturation on antiangiogenic therapy in ovarian cancer. Am J Obstet Gynecol (2008) 1.25
Histological findings of a choroidal neovascular membrane removed at the time of macular translocation in a patient previously treated with intravitreal bevacizumab treatment (Avastin). Br J Ophthalmol (2006) 1.11
Positive response to intravitreal ranibizumab in the treatment of choroidal neovascularization secondary to punctate inner choroidopathy. Retina (2010) 1.01
Surgical removal of subfoveal choroidal neovascularization without removal of posterior hyaloid: a consecutive series in younger patients. Retina (2001) 0.95
Photodynamic therapy combined with systemic corticosteroids for choroidal neovascularisation secondary to punctate inner choroidopathy. Eye (Lond) (2007) 0.92
Pathological findings of multifocal choroiditis with panuveitis and punctate inner choroidopathy. Jpn J Ophthalmol (2008) 0.90
Photodynamic therapy for subfoveal and juxtafoveal choroidal neovascularization associated with punctate inner choroidopathy. Ocul Immunol Inflamm (2007) 0.86
Osseous metaplasia in a preretinal membrane. Arch Ophthalmol (1997) 0.86
The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol (2004) 7.38
Messenger RNA for FOXP3 in the urine of renal-allograft recipients. N Engl J Med (2005) 5.02
The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int (2004) 4.77
Seven new loci associated with age-related macular degeneration. Nat Genet (2013) 3.81
Pathologic classification of diabetic nephropathy. J Am Soc Nephrol (2010) 3.61
Evolving guidelines for intravitreous injections. Retina (2004) 3.39
Genome-wide association study of advanced age-related macular degeneration identifies a role of the hepatic lipase gene (LIPC). Proc Natl Acad Sci U S A (2010) 3.33
A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema. Ophthalmology (2005) 3.20
Noninvasive diagnosis of BK virus nephritis by measurement of messenger RNA for BK virus VP1 in urine. Transplantation (2002) 2.86
Prevention of experimental choroidal neovascularization with intravitreal anti-vascular endothelial growth factor antibody fragment. Arch Ophthalmol (2002) 2.57
Proliferative glomerulonephritis with monoclonal IgG deposits: a distinct entity mimicking immune-complex glomerulonephritis. Kidney Int (2004) 2.39
MicroRNA expression profiles predictive of human renal allograft status. Proc Natl Acad Sci U S A (2009) 2.36
Conversion to aflibercept for chronic refractory or recurrent neovascular age-related macular degeneration. Am J Ophthalmol (2013) 2.32
Mitochondria-targeted peptide accelerates ATP recovery and reduces ischemic kidney injury. J Am Soc Nephrol (2011) 2.20
Concordance of antiretinal antibody testing results between laboratories in autoimmune retinopathy. JAMA Ophthalmol (2013) 2.15
Reactive retinal astrocytic tumors (so-called vasoproliferative tumors): histopathologic, immunohistochemical, and genetic studies of four cases. Am J Ophthalmol (2012) 2.12
A comparison of same setting versus delayed vitrectomy in the management of retained lens fragments after cataract surgery. Retina (2014) 2.00
Common variants near FRK/COL10A1 and VEGFA are associated with advanced age-related macular degeneration. Hum Mol Genet (2011) 1.98
Ultra-wide-field angiography improves the detection and classification of diabetic retinopathy. Retina (2012) 1.95
Collapsing glomerulopathy in 19 patients with systemic lupus erythematosus or lupus-like disease. Clin J Am Soc Nephrol (2012) 1.89
Pegaptanib sodium for neovascular age-related macular degeneration: two-year safety results of the two prospective, multicenter, controlled clinical trials. Ophthalmology (2006) 1.80
IgG4-related systemic disease as a cause of "idiopathic" orbital inflammation, including orbital myositis, and trigeminal nerve involvement. Surv Ophthalmol (2011) 1.75
Kidney tubular toxicity of maintenance pemetrexed therapy. Am J Kidney Dis (2011) 1.72
Peripheral retinal ischaemia, as evaluated by ultra-widefield fluorescein angiography, is associated with diabetic macular oedema. Br J Ophthalmol (2012) 1.71
Choroidal neovascularization after epiretinal membrane removal. Arch Ophthalmol (2006) 1.70
The expanded clinical spectrum of deferoxamine retinopathy. Ophthalmology (2002) 1.70
Acute macular neuroretinopathy: long-term insights revealed by multimodal imaging. Retina (2012) 1.68
Intravitreal bevacizumab for treatment of uveitic macular edema. Ophthalmology (2007) 1.66
Orbital involvement in Bing-Neel syndrome. J Neuroophthalmol (2010) 1.63
Nonsteroidal anti-inflammatory therapy and recurrent acute anterior uveitis. Ocul Immunol Inflamm (2010) 1.62
Dietary arginine supplementation attenuates renal damage after relief of unilateral ureteral obstruction in rats. Kidney Int (2005) 1.57
Phosducin facilitates light-driven transducin translocation in rod photoreceptors. Evidence from the phosducin knockout mouse. J Biol Chem (2004) 1.56
Retrocorneal membranes: a comparative immunohistochemical analysis of keratocytic, endothelial, and epithelial origins. Am J Ophthalmol (2010) 1.54
Seasonal variation of lupus nephritis: high prevalence of class V lupus nephritis during the winter and spring. J Rheumatol (2005) 1.53
Noninvasive detection of renal allograft inflammation by measurements of mRNA for IP-10 and CXCR3 in urine. Kidney Int (2004) 1.48
The case for observational management of suspected small choroidal melanoma. Arch Ophthalmol (2006) 1.43
Characterization of cytokine responses to retinal detachment in rats. Mol Vis (2006) 1.43
Paraneoplastic conjunctival cicatrization: two different pathogenic types. Ophthalmology (2010) 1.39
Review of genetics in age related macular degeneration. Semin Ophthalmol (2007) 1.37
Punctate inner choroidopathy: a survey analysis of 77 persons. Ophthalmology (2007) 1.36
The mitochondrial-targeted compound SS-31 re-energizes ischemic mitochondria by interacting with cardiolipin. J Am Soc Nephrol (2013) 1.35
Associations of CFHR1-CFHR3 deletion and a CFH SNP to age-related macular degeneration are not independent. Nat Genet (2010) 1.35
Anecortave acetate (15 milligrams) versus photodynamic therapy for treatment of subfoveal neovascularization in age-related macular degeneration. Ophthalmology (2005) 1.34
Proliferative lesions and metalloproteinase activity in murine lupus nephritis mediated by type I interferons and macrophages. Proc Natl Acad Sci U S A (2010) 1.33
Predictors of visual outcome and choroidal neovascular membrane formation after traumatic choroidal rupture. Arch Ophthalmol (2006) 1.32
Transducin gamma-subunit sets expression levels of alpha- and beta-subunits and is crucial for rod viability. J Neurosci (2008) 1.26
Inhibition of p66ShcA longevity gene rescues podocytes from HIV-1-induced oxidative stress and apoptosis. J Biol Chem (2009) 1.24
A new mouse model to explore therapies for preeclampsia. PLoS One (2010) 1.21
Acute posterior multifocal placoid pigment epitheliopathy: outcome and visual prognosis. Retina (2009) 1.19
Mast cells are required for the development of renal fibrosis in the rodent unilateral ureteral obstruction model. Am J Physiol Renal Physiol (2011) 1.18
The Nf2 tumor suppressor regulates cell-cell adhesion during tissue fusion. Proc Natl Acad Sci U S A (2007) 1.17
Successful treatment of Fusarium endophthalmitis with voriconazole and Aspergillus endophthalmitis with voriconazole plus caspofungin. Am J Ophthalmol (2005) 1.17
Retinal microvascular surgery: a feasibility study. Invest Ophthalmol Vis Sci (2004) 1.17
Management of vitreoretinal complications in eyes with permanent keratoprosthesis. Arch Ophthalmol (2002) 1.17
Pseudophakic cystoid macular edema. Semin Ophthalmol (2003) 1.16
Propranolol for isolated orbital infantile hemangioma. Arch Ophthalmol (2010) 1.15
Unifocal and multifocal reactive lymphoid hyperplasia vs follicular lymphoma of the ocular adnexa. Am J Ophthalmol (2010) 1.14
Cataract surgery as a risk factor for retinal detachment in very highly myopic eyes. Ophthalmology (2003) 1.13
Clinicopathologic reports, case reports, and small case series: surgical removal and histopathologic findings of a subfoveal neovascular membrane associated with choroidal osteoma. Arch Ophthalmol (2003) 1.10
Biologic response modifier therapy for psoriatic ocular inflammatory disease. Ocul Immunol Inflamm (2008) 1.09
Selective alpha-particle mediated depletion of tumor vasculature with vascular normalization. PLoS One (2007) 1.08
CD103 mRNA levels in urinary cells predict acute rejection of renal allografts. Transplantation (2003) 1.07
Renal tubulointerstitial changes after internal irradiation with alpha-particle-emitting actinium daughters. J Am Soc Nephrol (2005) 1.05
Effect of combination therapy with enalapril and the TGF-beta antagonist 1D11 in unilateral ureteral obstruction. Am J Physiol Renal Physiol (2006) 1.03
Mitigation of radiation nephropathy after internal alpha-particle irradiation of kidneys. Int J Radiat Oncol Biol Phys (2006) 1.02
Anecortave acetate as monotherapy for treatment of subfoveal neovascularization in age-related macular degeneration: twelve-month clinical outcomes. Ophthalmology (2003) 1.01
Subepidermal calcified nodule of the eyelid. Ophthal Plast Reconstr Surg (2008) 1.01
Infliximab for the treatment of refractory scleritis. Br J Ophthalmol (2009) 1.01
Increased choroidal neovascularization following laser induction in mice lacking lysyl oxidase-like 1. Invest Ophthalmol Vis Sci (2008) 1.01
Lamina puncture: pars plana optic disc surgery for central retinal vein occlusion. Arch Ophthalmol (2002) 1.00
Retinal toxicity of intravitreal triamcinolone acetonide: a morphological study. Retina (2006) 1.00
A novel cell-permeable antioxidant peptide decreases renal tubular apoptosis and damage in unilateral ureteral obstruction. Am J Physiol Renal Physiol (2008) 0.99
Renal damage progresses despite improvement of renal function after relief of unilateral ureteral obstruction in adult rats. Am J Physiol Renal Physiol (2004) 0.99
Discovery and validation of a molecular signature for the noninvasive diagnosis of human renal allograft fibrosis. Transplantation (2012) 0.98
B lymphocytes differentially influence acute and chronic allograft rejection in mice. J Immunol (2011) 0.98
Lymphoma-associated retinopathy. Ophthalmology (2002) 0.97
Canaliculops: clinicopathologic features and treatment with marsupialization. Am J Ophthalmol (2013) 0.96
Optical coherence tomography predicts visual outcome in macula-involving rhegmatogenous retinal detachment. Clin Ophthalmol (2012) 0.96
Disruption of the chaperonin containing TCP-1 function affects protein networks essential for rod outer segment morphogenesis and survival. Mol Cell Proteomics (2010) 0.96
Serine proteinase inhibitor-9, an endogenous blocker of granzyme B/perforin lytic pathway, is hyperexpressed during acute rejection of renal allografts. Transplantation (2003) 0.96
Severe bilateral ischemic retinal vasculitis following cataract surgery. Ophthalmic Surg Lasers Imaging Retina (2014) 0.96
Novel cardiolipin therapeutic protects endothelial mitochondria during renal ischemia and mitigates microvascular rarefaction, inflammation, and fibrosis. Am J Physiol Renal Physiol (2014) 0.94
Characterization of retrokeratoprosthetic membranes in the Boston type 1 keratoprosthesis. Arch Ophthalmol (2011) 0.94
Diagnostic testing and disease monitoring in birdshot chorioretinopathy. Semin Ophthalmol (2011) 0.94
Rhodopsin expression level affects rod outer segment morphology and photoresponse kinetics. PLoS One (2012) 0.93
Correlation of CD4 counts with renal disease in HIV positive patients. Saudi J Kidney Dis Transpl (2008) 0.93
Clinicopathologic and immunohistochemical features of pigmented Basal cell carcinomas of the eyelids. Am J Ophthalmol (2011) 0.92
Erythroid transcription factor EKLF/KLF1 mutation causing congenital dyserythropoietic anemia type IV in a patient of Taiwanese origin: review of all reported cases and development of a clinical diagnostic paradigm. Blood Cells Mol Dis (2013) 0.91
Inhibitory effect of aminoimidazole carboxamide ribonucleotide (AICAR) on endotoxin-induced uveitis in rats. Invest Ophthalmol Vis Sci (2011) 0.91
Selective photodynamic therapy by targeted verteporfin delivery to experimental choroidal neovascularization mediated by a homing peptide to vascular endothelial growth factor receptor-2. Arch Ophthalmol (2004) 0.91
Systemic immunomodulatory therapy in severe dry eye secondary to inflammation. Ocul Immunol Inflamm (2007) 0.91
Improved tumor imaging and therapy via i.v. IgG-mediated time-sequential modulation of neonatal Fc receptor. J Clin Invest (2007) 0.90
Contribution of pneumolysin and autolysin to the pathogenesis of experimental pneumococcal endophthalmitis. Retina (2002) 0.89
Conjunctival/corneal intraepithelial neoplasia. Int Ophthalmol Clin (2009) 0.89
Giant dacryocystomucopyocele in an adult: a review of lacrimal sac enlargements with clinical and histopathologic differential diagnoses. Surv Ophthalmol (2012) 0.89
Ocular cicatricial pemphigoid: a review of clinical features, immunopathology, differential diagnosis, and current management. Semin Ophthalmol (2011) 0.89
The use of biologic agents in the treatment of ocular manifestations of Behcet's disease. Semin Ophthalmol (2011) 0.89